Search Results - "Dorca, J"

Anti-fibrotic effects of pirfenidone and rapamycin in primary IPF fibroblasts and human alveolar epithelial cells by Molina-Molina, M, Machahua-Huamani, C, Vicens-Zygmunt, V, Llatjós, R, Escobar, I, Sala-Llinas, E, Luburich-Hernaiz, P, Dorca, J, Montes-Worboys, A

“…Pirfenidone, a pleiotropic anti-fibrotic treatment, has been shown to slow down disease progression of idiopathic pulmonary fibrosis (IPF), a fatal and…”
Get full text

A prospective study of lung disease in a cohort of early rheumatoid arthritis patients by Robles-Pérez, A., Luburich, P., Bolivar, S., Dorca, J., Nolla, J. M., Molina-Molina, M., Narváez, J.

“…Lung disease is common in patients with rheumatoid arthritis (RA). The onset of lung involvement in RA is not well known. The objective is to describe the…”
Get full text

Prognostic factors for relapse in stage I seminoma: a new nomogram derived from three consecutive, risk-adapted studies from the Spanish Germ Cell Cancer Group (SGCCG) by Aparicio, J., Maroto, P., García del Muro, X., Sánchez-Muñoz, A., Gumà, J., Margelí, M., Sáenz, A., Sagastibelza, N., Castellano, D., Arranz, J.A., Hervás, D., Bastús, R., Fernández-Aramburo, A., Sastre, J., Terrasa, J., López-Brea, M., Dorca, J., Almenar, D., Carles, J., Hernández, A., Germà, J.R.

“…We aimed to analyze prognostic factors for relapse in stage I seminoma managed by either active surveillance or adjuvant chemotherapy, and to describe the…”
Get full text

Declining mortality among hospitalized patients with community-acquired pneumonia by Simonetti, A.F., Garcia-Vidal, C., Viasus, D., García-Somoza, D., Dorca, J., Gudiol, F., Carratalà, J.

“…Little information is available on the changes over time in community-acquired pneumonia (CAP) management and their impact on 30-day mortality in hospitalized…”
Get full text

Calcium enhances binding of Clostridium perfringens epsilon toxin to sulfatide by Gil, C., Dorca-Arévalo, J., Blasi, J.

“…Epsilon toxin (Etx) from Clostridium perfringens is synthesized as a very low-active prototoxin form (proEtx) that becomes active upon proteolytic activation…”
Get full text

Low incidence of multidrug-resistant organisms in patients with healthcare-associated pneumonia requiring hospitalization by Garcia-Vidal, C., Viasus, D., Roset, A., Adamuz, J., Verdaguer, R., Dorca, J., Gudiol, F., Carratalà, J.

“…Healthcare-associated pneumonia (HCAP) includes a broad spectrum of patients who acquire pneumonia through outpatient contact with the health system. Although…”
Get full text

Increasing isolation of rapidly growing mycobacteria in a low-incidence setting of environmental mycobacteria, 1994–2015 by Alcaide, F., Peña, M. J., Pérez-Risco, D., Camprubi, D., Gonzalez-Luquero, L., Grijota-Camino, M. D., Dorca, J., Santin, M.

“…To determine trends in incidence and clinical relevance of rapidly growing mycobacteria (RGM) in a low-prevalence region of non-tuberculous mycobacteria. We…”
Get full text

Pneumococcal pneumonia presenting with septic shock: host- and pathogen-related factors and outcomes by Garcia-Vidal, C, Ardanuy, C, Tubau, F, Viasus, D, Dorca, J, Liñares, J, Gudiol, F, Carratalà, J

“…Host- and pathogen-related factors associated with septic shock in pneumococcal pneumonia are not well defined. The aim of this study was to identify risk…”
Get more information

Early mortality in patients with community-acquired pneumonia: causes and risk factors by Garcia-Vidal, C, Fernandez-Sabe, N, Carratala, J, Diaz, V, Verdaguer, R, Dorca, J, Manresa, F, Gudiol, F

“…The first 48 h of evolution of patients with community-acquired pneumonia (CAP) are critical. The aim of the present study was to determine the frequency,…”
Get full text

Obstructive sleep apnoea and metabolic impairment in severe obesity by GASA, M, SALORD, N, FORTUNA, A. M, MAYOS, M, VILARRASA, N, DORCA, J, MONTSERRAT, J. M, BONSIGNORE, M. R, MONASTERIO, C

“…Obstructive sleep apnoea (OSA) seems to worsen metabolism. This effect has not been evaluated in morbid obesity (MO). We hypothesised that the metabolic…”
Get full text

Primary results of the first nationwide molecular screening program in Spain for patients with advanced breast cancer (AGATA SOLTI-1301 study) by Pernas, S., Villagrasa, P., Vivancos, A., Scaltriti, M., Rodon, J., Burgues, O., Nuciforo, P.G., Canes, J., Dueñas, M., Vidal, M., Lluch, A., Perelló, A., Llombart, A., Dorca, J., Montaño, Á, Oliveira, M., Ribas, G., Rapado, I., Prat, A., Ciruelos, E.M.

Get full text

Incorporating the antidiabetic drug metformin in HER2-positive breast cancer treated with neo-adjuvant chemotherapy and trastuzumab: an ongoing clinical–translational research experience at the Catalan Institute of Oncology by Martin-Castillo, B., Dorca, J., Vazquez-Martin, A., Oliveras-Ferraros, C., Lopez-Bonet, E., Garcia, M., del Barco, S., Menendez, J. A.

Get full text

Timing of antibiotic administration and outcomes of hospitalized patients with community-acquired and healthcare-associated pneumonia by Simonetti, A., Viasus, D., Garcia-Vidal, C., Adamuz, J., Roset, A., Manresa, F., Dorca, J., Gudiol, F., Carratalà, J.

“…The effects of antibiotic timing on outcomes of patients with community-acquired pneumonia (CAP) are controversial. Moreover, no information is available…”
Get full text

Clinical Outcomes for Hospitalized Patients with Legionella Pneumonia in the Antigenuria Era: The Influence of Levofloxacin Therapy by Mykietiuk, Analía, Carratalà, Jordi, Fernández-Sabé, Núria, Dorca, Jordi, Verdaguer, Ricard, Manresa, Frederic, Gudiol, Francesc

“…Background. Although the reduction in case-fatality rate recently observed among patients with Legionella pneumonia has been largely attributed to the…”
Get full text

Impact of pre-hospital antibiotic use on community-acquired pneumonia by Simonetti, A.F., Viasus, D., Garcia-Vidal, C., Grillo, S., Molero, L., Dorca, J., Carratalà, J.

“…Information on the influence of pre-hospital antibiotic treatment on the causative organisms, clinical features and outcomes of patients with…”
Get full text

Aetiology of, and risk factors for, recurrent community-acquired pneumonia by Garcia-Vidal, C., Carratalà, J., Fernández-Sabé, N., Dorca, J., Verdaguer, R., Manresa, F., Gudiol, F.

“…Recurrent community-acquired pneumonia (CAP) requiring hospitalization is a matter of particular concern. However, current information on its prevalence,…”
Get full text

Long-term relapses after 12-month treatment for Mycobacterium kansasii lung disease by Santin, M, Dorca, J, Alcaide, F, Gonzalez, L, Casas, S, Lopez, M, Guerra, M. R

“…Long-lasting therapy for Mycobacterium kansasii lung disease with rifampin-containing multidrug regimens is needed to avoid relapses. The aim of the present…”
Get full text

Impact of acute exacerbations on platelet reactivity in chronic obstructive pulmonary disease patients by Muñoz-Esquerre, Mariana, Ferreiro, José Luis, Huertas, Daniel, Marcano, Ana Lucrecia, López-Sánchez, Marta, Roura, Gerard, Gómez-Hospital, Joan Antoni, Dorca, Jordi, Cequier, Angel, Santos, Salud

“…A higher risk of atherothrombotic cardiovascular events, which are platelet-driven processes, has been described during acute exacerbations of chronic…”
Get full text

Effect of prior pneumococcal vaccination on clinical outcome of hospitalized adults with community-acquired pneumococcal pneumonia by MYKIETIUK, A, CARRATALA, J, DOMINGUEZ, A, MANZUR, A, FERNANDEZ-SABE, N, DORCA, J, TUBAU, F, MANRESA, F, GUDIOL, F

“…The aim of this study was to evaluate the effect of prior pneumococcal vaccination on the clinical outcome of 554 consecutive hospitalized adults with…”
Get full text

Specific IgA against Pseudomonas aeruginosa in severe COPD by Millares, Laura, Martí, Sara, Ardanuy, Carmen, Liñares, Josefina, Santos, Salud, Dorca, Jordi, García-Nuñez, Marian, Quero, Sara, Monsó, Eduard

“…The bronchial mucosa is protected by a specialized immune system focused on the prevention of colonization and infection by potentially pathogenic…”
Get full text